Open AccessAssociation of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012
Author(s) -
Sylvia K. Plevritis,
Diego A. Muñoz,
Allison W. Kurian,
Natasha K. Stout,
Oğuzhan Alagöz,
Aimee M. Near,
Sandra J. Lee,
Jeroen J. van den Broek,
Xuelin Huang,
Clyde B. Schechter,
Brian L. Sprague,
Juhee Song,
Harry J. de Koning,
Amy TrenthamDietz,
Nicolien T. van Ravesteyn,
Ronald E. Gang,
Young Chandler,
Yisheng Li,
Cong Xu,
Mehmet Ali Ergün,
Hui Huang,
Donald A. Berry,
Jeanne S. Mandelblatt
Publication year - 2018
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.19130
Subject(s) - medicine , breast cancer , mammography , oncology , cancer , mortality rate , trastuzumab , gynecology , demography , sociology
Given recent advances in screening mammography and adjuvant therapy (treatment), quantifying their separate and combined effects on US breast cancer mortality reductions by molecular subtype could guide future decisions to reduce disease burden.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom